N. Paolocci et al., Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo bycalcitonin gene-related peptide signaling, P NAS US, 98(18), 2001, pp. 10463-10468
Citations number
37
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Nitroxyl anion (NO-) is the one-electron reduction product of nitric oxide
(NO.) and is enzymatically generated by NO synthase in vitro. The physiolog
ic activity and mechanism of action of NO- in vivo remains unknown. The NO-
generator Angeli's salt (AS, Na2N2O3) was administered to conscious chroni
cally instrumented dogs, and pressure-dimension analysis was used to discri
minate contractile from peripheral vascular responses. AS rapidly enhanced
left ventricular contractility and concomitantly lowered cardiac preload vo
lume and diastolic pressure (venodilation) without a change in arterial res
istance. There were no associated changes in arterial or venous plasma cGMP
. The inotropic response was similar despite reflex blockade with hexametho
nium or volume reexpansion, indicating its independence from baroreflex sti
mulation. However, reflex activation did play a major role in the selective
venodilation observed under basal conditions. These data contrasted with t
he pure NO donor diethylamine/NO, which induced a negligible inotropic resp
onse and a more balanced veno/arterial dilation. AS-induced positive inotro
py, but not systemic vasodilatation, was highly redox-sensitive, being virt
ually inhibited by coinfusion of N-acetyl-L-cysteine. Cardiac inotropic sig
naling by NO- was mediated by calcitonin gene-related peptide (CGRP), as tr
eatment with the selective CGRP-receptor antagonist CGRP-(8-37) prevented t
his effect but not systemic vasodilation. Thus, NO- is a redox-sensitive po
sitive inotrope with selective venodilator action, whose cardiac effects ar
e mediated by CGRP-receptor stimulation. This fact is evidence linking NO-
to redox-sensitive cardiac contractile modulation by nonadrenergic/noncholi
nergic peptide signaling. Given its cardiac and vascular properties, NO- ma
y prove useful for the treatment of cardiovascular diseases characterized b
y cardiac depression and elevated venous filling pressures.